Figure 3. Adjusted patient factors associated with overall OAC use within 1 year from AF diagnosis in total AF population (A) and patients with CHA₂DS₂-VASc score ≥2 (B).

CKD = chronic kidney disease; ESRD = end-stage renal disease; COPD = chronic obstructive pulmonary disease; TIA = transient ischemic attack; NOAC = non-vitamin K antagonist oral anticoagulant; OAC = oral anticoagulant; CI = confidence interval; AF = atrial fibrillation; CHA₂DS₂-VASc = congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female).